Calcipotriol Ointment 50 micrograms/g

DRUG2 trials

Sponsors

University Hospital Maastricht, Cadila Pharnmaceuticals

Conditions

Actinic KeratosisMild to Moderate Plaque Psoriasis

Phase 3

A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis

CompletedNCT05174598

Cadila PharnmaceuticalsMild to Moderate Plaque Psoriasis

Start: 2018-10-03End: 2020-12-03Updated: 2022-03-03

Phase 4

Combination therapy of 5-Fluorouracil and Calcipotriol versus 5-Fluorouracil in the treatment of Actinic Keratosis: a multicentre randomized controlled clinical trial

Active, not recruitingCTIS2024-511409-42-00

University Hospital MaastrichtActinic Keratosis

Start: 2024-09-02Target: 232Updated: 2024-09-24